INT273354

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.04
First Reported 2009
Last Reported 2009
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.19
Pain Relevance 0.09

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

nuclear envelope (ALOX5, LTC4S) small molecule metabolic process (ALOX5, LTC4S) nucleus (ALOX5, LTC4S)
lyase activity (LTC4S) endoplasmic reticulum (LTC4S) cytoplasm (ALOX5)
ALOX5 (Homo sapiens)
LTC4S (Homo sapiens)
Pain Link Frequency Relevance Heat
Inflammation 11 69.36 Quite High
Inflammatory mediators 2 47.44 Quite Low
cINOD 1 5.00 Very Low Very Low Very Low
Bioavailability 1 5.00 Very Low Very Low Very Low
antagonist 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
INFLAMMATION 13 69.36 Quite High
Occupational Lung Diseases 1 27.72 Quite Low
Hypersensitivity 6 5.00 Very Low Very Low Very Low
Increased Venous Pressure Under Development 3 5.00 Very Low Very Low Very Low
Asthma 3 5.00 Very Low Very Low Very Low
Overdose 1 5.00 Very Low Very Low Very Low
Rhinitis 1 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
A possible explanation of the inhibitory effects of NCX2057 in the present study, is therefore that this lipophilic NO donor has the potential to inhibit de novo synthesis of leukotrienes and prostanoids via interaction with iron centre in 5-lipoxygenase and cyclooxygenase enzymes [34,35], and via interaction with thiol groups on LTC4 synthase [34].
5-lipoxygenase Binding (interaction) of LTC4 synthase
1) Confidence 0.04 Published 2009 Journal Respir Res Section Body Doc Link PMC2696438 Disease Relevance 0.19 Pain Relevance 0.09

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox